Abstract:Key PointsThe Hedgehog signalling pathway has diverse functions in animal development and tissue homeostasis. Dysregulation of the pathway has been implicated in several developmental syndromes and cancers.The production of Hedgehog (HH) ligands involves autoproteolytic cleavage and the addition of lipid moieties such as cholesterol and palmitic acid. Several dedicated proteins are required for the secretion of the ligand.Novel mechanisms involving ligand multimerization, complex formation with additional soluble proteins and association with components of the extracellular matrix, such as the heparan sulphate proteoglycans, have been proposed to explain the dispersion of lipidated HH proteins through tissues.Signal transduction requires a number of transmembrane proteins, most notably Patched 1 (PTC) and Smoothened (SMO). The mechanism by which the signal is transduced from PTC to SMO is unclear. Strikingly, in vertebrates, but not Drosophila melanogaster, signal transduction requires the primary cilia of cells, identifying a function for this previously enigmatic organelle.Intracellularly, signalling involves Suppressor of Fu (SUFU), the kinesin proteins Costal 2 (Cos2) in D. melanogaster and KIF7 in vertebrates and several kinases. Signalling culminates with the regulation of the D. melanogaster Cubitus interruptus (Ci) and vertebrate GLI families of transcription factors. HH signalling converts the Ci and GLI proteins from transcriptional repressors to activators by inhibiting their proteolytic cleavage.The various functions of HH signalling have predominately been ascribed to its regulation of gene expression, and the relevant transcriptional networks are beginning to be dissected. Recently, however, non-canonical branches to the signalling pathway have been found, and these might contribute to some HH functions.HH signalling regulates the survival and proliferation of tissue progenitor and stem populations. This function is linked to its role in tumour formation. Several small-molecule antagonists and agonists that target SMO have been identified, and these show promise in the treatment of HH-related pathologies. In 2012, the approval of the Food and Drug Administration (FDA) was obtained for the first drug that targets HH signalling in the skin cancer basal cell carcinoma.

Opposing Roles for Glypicans in Hedgehog Signalling

Structure of the protein core of the glypican Dally-like and localization of a region important for hedgehog signaling

The Cell-Surface Proteins Dally-Like And Ihog Differentially Regulate Hedgehog Signaling Strength And Range During Development

Hedgehog on the Move: Glypican-Regulated Transport and Gradient Formation in Drosophila

Functions of Heparan Sulfate Proteoglycans in Cell Signaling During Development

Developmental roles of heparan sulfate proteoglycans in Drosophila

Role of glypican-1 in regulating multiple cellular signaling pathways

Drosophila Glypicans Control the Cell-To-Cell Movement of Hedgehog by A Dynamin-Independent Process

Dual Roles of Drosophila Glypican Dally-like in Wingless/Wnt Signaling and Distribution.

Recent Progress in the Study of Hedgehog Signaling

The mechanisms of Hedgehog signalling and its roles in development and disease

Loss of the Heparan Sulfate Proteoglycan Glypican5 Facilitates Long-Range Sonic Hedgehog Signaling

Regulation of Smoothened Phosphorylation and High-Level Hedgehog Signaling Activity by a Plasma Membrane Associated Kinase

Protein Modifications in Hedgehog Signaling

The Core Protein of Glypican Dally-like Determines Its Biphasic Activity in Wingless Morphogen Signaling.

Hedgehog Signalling Activity of Smoothened Requires Phosphorylation by Protein Kinase A and Casein Kinase I

Protein Modifications in Hedgehog Signaling: Cross Talk and Feedback Regulation Confer Divergent Hedgehog Signaling Activity.

Current Status of Hedgehog Signaling Inhibitors

Hedgehog ligand and receptor cooperatively regulate EGFR stability and activity in non-small cell lung cancer

Altering Glypican-1 levels modulates canonical Wnt signaling during trigeminal placode development

The Role of Glypican-1 in the Tumour Microenvironment